Answers are grounded in this paper and cite their sources.
We demonstrated cross-reactive anti-SARS-CoV-2 antibodies in prepandemic serum samples from children and young adults. Promoting this cross-reactive immunity and memory response derived from common HCoV may be an effective strategy against SARS-COV-2 and future novel coronaviruses.
No takes yet. Share an insight, caveat, or question.
Shrwani et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: